What is the translation of " PATIENTS DEVELOP " in Slovenian?

• bolniki razvijejo
• bolnikov razvije

Examples of using Patients develop in English and their translations into Slovenian

Most patients develop one or more foci of hair loss.
Večina bolnikov razvije eno ali več lezij izpadanja las.

At 75% coronary stenosis, the heart muscle cells respond to oxygen deficiency, and patients develop angina.
Pri 75% koronarne stenoze se celice srčne mišice odzovejo na pomanjkanje kisika in bolniki razvijejo angino pektoris.

In some cases, patients develop cognitive and communicational impairments.
V nekaterih primerih bolniki razvijejo trofične in vazomotorične motnje.

This can lead to muscle weakness, confusion and memory problems, dry skin, and feelings of numbness and tingling, but some patients develop cancer of the lymph tissue as well.
To lahko povzroči oslabelost mišic, zmedo in težave pomnilnika, suho kožo, in občutek odrevenelost in mravljinčenje, vendar nekateri bolniki razvijejo raka je limfatičnega tkiva tudi.

In 1/3 patients develop kidney degeneration, which leads to renal failure.
Pri 1/3 bolnikov razvije ledvic degeneracija, kar vodi v odpoved ledvic.

Because of the decrease in the number of neurosteroids, patients develop depression, although this side effect is extremely rare.
Bolniki razvijejo depresijo zaradi zmanjšanja števila nevrosteroidov, čeprav je ta neželeni učinek zelo redek.

Patients develop a serious headache and stiff neck and may become unconscious.
Bolniki razvijejo hud glavobol in otrdel vrat in lahko postanejo nezavestni.

In severe, advanced cases, patients develop a syndrome of the vertebral artery.
V hudih, naprednih primerih bolniki razvijejo sindrom vretenčne arterije.

Patients develop persistent irreversible neurologic disorders, a lethal outcome is possible.
Bolniki razvijejo trajne ireverzibilne nevrološke motnje, možen je smrtni izid.

Because of the decrease in the number of neurosteroids, patients develop depression, although this side effect is extremely rare.
Zaradi zmanjšanja števila nevrosteroidov bolniki razvijejo depresijo, čeprav je ta neželeni učinek zelo redek.

Some patients develop hypersensitivity when gugglesterone is used continuously for weeks or months.
Nekateri bolniki razvijejo preobčutljivost gugglsterone z nadaljnjo uporabo zdravilo več tednov ali celo mesecev.

Prolonged hypothyroidism can result in a condition called myxedema in which patients develop thickened nose, swollen lips and unusual deposits of material in the skin that are dry and waxy.
Posledica hipotiroidizma je lahko stanje, imenovano miksedem, pri katerem bolniki razvijejo otekle ustnice, zgoščen nos in nenavadne depozite materiala v suhi in voski koži.

Many patients develop swallowing problems which may lead to recurrent episodes of pneumonia, a frequent cause of death.
Mnogi bolniki razvijejo težave pri požiranju, ki lahko privede do ponavljajočih se epizod pljučnice, pogost vzrok smrti.

Clinical data suggest that after 24 to 48 months of treatment with Rebif 22 micrograms, approximately 24% of patients develop persistent serum antibodies to interferon beta-1a.
Klinični podatki kažejo, da se po 24 do 48 mesecih zdravljenja z zdravilom Rebif 22 mikrogramov, približno pri 24% bolnikov razvije vztrajen pojav serumskih protiteles na interferon beta- 1a.

In some cases, patients develop a so-called fulminant acute hepatitis.
V nekaterih primerih se bolniki razvijejo tako imenovani fulminantni akutni hepatitis.

Secondary cutaneous lesions may appear in other regions. In the second stage, seen weeks or months later, some patients develop disseminated disease.
Na drugih mestih se lahko pojavijo sekundarne kožne spremembe.V drugi fazi, ki se začne po nekaj tednih ali mesecih, se pri nekaterih bolnikih razvije splošno obolenje- generalizirana oblika.

Rarely will patients develop complications such as relapsing hepatitis or liver failure.
Redko se bodo pri bolnikih pojavili zapleti, kot sta recidivni hepatitis ali odpoved jeter.

Patients develop ADAs after repeated administration, the cross-reactivity of which versus endogenous MMPs involved in pregnancy and labour cannot be excluded.
Po večkratnih aplikacijah bolniki razvijejo protitelesa ADA, katerih križne reaktivnosti proti endogenim MMP, ki so vključeni v nosečnost in porod, ne moremo izključiti.

For example, patients develop cataracts, irites, uveitis, corneal dystrophy, glaucoma, lesions of the optic nerve.
Na primer, pri bolnikih se pojavijo katarakte, iriti, uveitis, distrofija roženice, glavkom, poškodbe vidnega živca.

In the future, patients develop an aversion to food, nausea, vomiting, mouth appear distinctive sweet odor(hepatic).
V prihodnosti bolniki razvijejo popolno averzijo na hrano, slabost, bruhanje, iz ust se pojavi poseben vonj po vonju(jetra).

Psychotherapy helps patients develop skills of emotional self-regulation and in the future to more effectively cope with the crisis without sinking into a depression.
Psihoterapija uči bolniki razvijejo čustveno samoregulacijo, in v prihodnosti, da si opomore od kriznih razmerah ne predajo moči depresije.

Psychotherapy helps patients develop the skills of emotional self-regulation and in the future more effectively cope with crisis situations, without plunging into depression.
Psihoterapija uči bolniki razvijejo čustveno samoregulacijo, in v prihodnosti, da si opomore od kriznih razmerah ne predajo moči depresije.

Very rarely, patients develop Neuroleptic Malignant Syndrome(severe symptoms of muscle stiffening, fever or mental confusion) when antiparkinsonian treatments are abruptly reduced or withdrawn.
Zelo redko bolniki razvijejo maligni nevroleptični sindrom(resni simptomi mišične togosti, zvišana telesna temperatura ali zmedenost), ko se zdravila za zdravljenje parkinsonizma nenadno zmanjšajo ali ukinejo.

Sometimes these patients develop acute anterior uveitis. Unlike uveitis with other JIA forms, it usually presents with red and watery eyes(lachrymation) and increased sensitivity to light.
Včasih se pri teh bolnikih pojavi akutni anteriorni uveitis, pri katerem se, drugače kot pri ostalih oblikah JIA, pojavi tudi rdeče oko, solzenje in povečana občutljivost za svetlobo.

If patients develop sustained, unexplained, clinically significant ALT and/ or AST elevation, or if ALT and/ or AST elevation is accompanied by signs or symptoms of hepatic injury(e. g. jaundice), Volibris therapy should be discontinued.
Če se pri bolniku razvije trdovratno, nepojasnjeno, klinično pomembno zvišanje ALT ali AST ali obeh, ali zvišanje vrednosti ALT ali AST ali obeh spremljajo znaki in simptomi okvare jeter(npr. zlatenica), je treba zdravljenje z zdravilom Volibris prekiniti.

Treatment with asparaginase should be interrupted if patients develop severe hepatic impairment(bilirubingt; 3 times the upper limit of normal[ULN]; transaminasesgt; 10 times ULN), severe hypertriglyceridaemia, hyperglycaemia or coagulation disorder(e.g. sinus vein thrombosis, severe bleeding).
Zdravljenje z asparaginazo je treba prekiniti, če se pri bolnikih razvije huda okvara jeter(bilirubingt; 3- krat zgornja meja normalnih vrednosti[ULN-upper limitof normal]; transaminazegt; 10-krat višje od ULN), huda hipertrigliceridemija, hiperglikemija ali motnja koagulacije(npr. tromboza venskih sinusov, huda krvavitev).

Treatment should be discontinued if the patient develops chronic progressive MS.
Zdravljenje je potrebno prekiniti, če se pri bolniku razvije kronična napredujoča MS.

If a patient develops PML, the dosing of rituximab must be permanently discontinued.
Če se pri bolniku razvije PML, je treba uporabo zdravila Ritemvia dokončno ukiniti.

If a patient develops PML the dosing of MabThera must be permanently discontinued.
Če se pri bolniku razvije PML, je treba zdravljenje z zdravilom MabThera dokončno ukiniti.

Rilonacept Regeneron should be discontinued if a patient develops a serious infection.
Zdravilo Rilonacept Regeneron moramo ukiniti, če se pri bolniku razvije resna okužba.